Physician Profile
Yuli McCann, MD is a healthcare provider in Seattle, WA specializing in rheumatology. Yuli trained at University of Washington School of Medicine, graduating in 2007. Medicare claims data shows Yuli provided 16,765 services to 817 patients. The services billed most often include injection, golimumab, 1 mg, for intravenous use, injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered), and injection, infliximab, excludes biosimilar, 10 mg.
Summarised automatically from public NPI registry and CMS Medicare data. Not written or reviewed by this provider. Claim this profile to replace it.
License numbers are what the provider reported to NPPES when the NPI was issued or updated. NPPES does not verify licensure; confirm current standing with the state licensing board.
Exactly as CMS reports it (National Downloadable File, Opt-Out Affidavits, Order & Referring). Not an insurance directory; confirm coverage with the office.
10330 MERIDIAN AVE N SUITE 250
Seattle, WA 98133
Within Rheumatology generally. Availability varies by clinician, training and location — this profile has not been claimed, so nothing here is a personal claim by the provider.
Most searched conditions
Autoimmune
Bone
Bone Health
Connective Tissue
Genetic & Connective Tissue
Inflammatory
Joints
Nerve & Tendon
Skin & Soft Tissue
Skin & Vascular
Soft Tissue
Spine & Back
Vascular
Most searched procedures
Consultation
Consultations
Diagnostics & Injections
Education & Support
Imaging
Injections
Lab & Diagnostics
Lab Work
Medication Management
Pain Relief
Regenerative Medicine
16,765 services · 817 patients · 14 distinct codes
| Procedure | Type | Code | Services | Compared with peers |
|---|---|---|---|---|
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Treatment | 96365 |
192 | More often than most peers in Rheumatology |
| Administration of chemotherapy into vein, 1 hour or less | Treatment | 96413 |
82 | |
| Administration of chemotherapy into vein, each additional hour | Treatment | 96415 |
69 | |
| Injection of additional new drug or substance into vein | Treatment | 96375 |
32 | |
| Injection, golimumab, 1 mg, for intravenous use | Drug given | J1602 |
5,657 | |
| Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Drug given | J0129 |
4,975 | |
| Injection, infliximab, excludes biosimilar, 10 mg | Drug given | J1745 |
2,440 | |
| Injection, rituximab, 10 mg | Drug given | J9312 |
1,650 | |
| Injection, zoledronic acid, 1 mg | Drug given | J3489 |
145 | As often as other peers in Rheumatology |
| Infusion, normal saline solution, 250 cc | Drug given | J7050 |
105 | As often as other peers in Rheumatology |
Source: CMS Medicare public data. Shows how often procedures were billed — not quality of care or patient satisfaction.
Dr. McCann is a rheumatologist in Seattle, WA. That is the designation recorded for this NPI in the federal registry, where it is listed as “Rheumatology”.
NPI registry
Dr. McCann is listed at 10330 Meridian Ave N Suite 250, Seattle, WA 98133. Addresses come from the NPI registry and can lag a move, so confirm before travelling.
NPI registry
The number on file is (206) 368-6123. Guide.md cannot book appointments or pass on messages — please call the office directly.
NPI registry
Dr. McCann's National Provider Identifier is 1619169729. It is issued by the Centers for Medicare & Medicaid Services and is unique and permanent — it does not change if they move practice.
NPI registry
Dr. McCann attended University of Washington School of Medicine, graduating in 2007. This comes from the CMS National Downloadable File.
CMS public data
Dr. McCann has 19 years experience. Calculated from a graduation year of 2007, reported in the CMS National Downloadable File.
CMS public data
According to Medicare billing data, Dr. McCann provides treatments such as infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less and administration of chemotherapy into vein, 1 hour or less, alongside routine visits and testing. This reflects Medicare patients only and is billing volume, not a measure of quality.
Medicare claims
Not yet. This profile is built from public federal data and has not been confirmed by Dr. McCann. If this is you, claiming it is free.
Guide.md
Provider data sourced from the NPPES NPI Registry and CMS public datasets. Information is provided for reference and is not medical advice.